WO2005011591A3 - Method for the treatment of sleep disorders - Google Patents

Method for the treatment of sleep disorders Download PDF

Info

Publication number
WO2005011591A3
WO2005011591A3 PCT/US2004/024596 US2004024596W WO2005011591A3 WO 2005011591 A3 WO2005011591 A3 WO 2005011591A3 US 2004024596 W US2004024596 W US 2004024596W WO 2005011591 A3 WO2005011591 A3 WO 2005011591A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
sleep disorders
sleep
disorders
pantoprazole
Prior art date
Application number
PCT/US2004/024596
Other languages
French (fr)
Other versions
WO2005011591A2 (en
Inventor
David L Steward
Richard B Lynn
Original Assignee
Altana Pharma Ag
David L Steward
Richard B Lynn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag, David L Steward, Richard B Lynn filed Critical Altana Pharma Ag
Publication of WO2005011591A2 publication Critical patent/WO2005011591A2/en
Publication of WO2005011591A3 publication Critical patent/WO2005011591A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a new use of pantoprazole.
PCT/US2004/024596 2003-08-01 2004-07-30 Method for the treatment of sleep disorders WO2005011591A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49156003P 2003-08-01 2003-08-01
US60/491,560 2003-08-01

Publications (2)

Publication Number Publication Date
WO2005011591A2 WO2005011591A2 (en) 2005-02-10
WO2005011591A3 true WO2005011591A3 (en) 2005-04-28

Family

ID=34115520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/024596 WO2005011591A2 (en) 2003-08-01 2004-07-30 Method for the treatment of sleep disorders

Country Status (1)

Country Link
WO (1) WO2005011591A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1879577A1 (en) * 2005-05-04 2008-01-23 AstraZeneca AB Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same

Also Published As

Publication number Publication date
WO2005011591A2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
AU2003286567A1 (en) Methods for the treatment of skin disorders
EG26605A (en) Method for the production of 4-(4-aminophenyl)-3-morpholinon
AU2003297761A1 (en) Methods for treating neurological language disorders
SI1474416T1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
IL176393A (en) Patterned laser treatment of the retina
IL176296A0 (en) Method for the production of an administration form which is secured against misuse
ZA200702523B (en) Process for the purification of 1,4-butanediol
AU2003249983A1 (en) Piperidines useful for the treatment of central nervous system disorders
AU2003258855A1 (en) Method for the reduction of acrylamide formation
AU2003210597A1 (en) Methods for treating eye disorders
HK1064261A1 (en) Method for the treatment of tobacco.
AU2001285747A1 (en) Method for the treatment of tobacco
EP1667827A4 (en) Process for the treatment of wood
AU2003233820A1 (en) Method for the treatment of starch
WO2004092481A3 (en) Method for the treatment of paper surfaces
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
WO2005011591A3 (en) Method for the treatment of sleep disorders
AU2003293272A1 (en) Method for the production of bioprostheses
AU2003292209A8 (en) Method for the production of optically active dihydropyrones
AU2003243214A1 (en) Salts of bis-arylsulfones for the treatment of cns disorders
AU2003239967A1 (en) Compound for the treatment of cns disorders
HRP20041159A2 (en) Combination for the treatment of airway disorders
AU2003233239A1 (en) Method for the production of polymethylenepolysulfides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase